Related Experiment Video
Updated: Jun 3, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Central nervous system inflammation and prion disease pathogenesis
1CNS Inflammation Group, School of Biological Sciences, University of Southampton, Southampton, UK.
Abstract:
The study of inflammation in the prion diseases is relatively new. Indeed, for a number of years the accepted dogma was that the prion diseases lacked an inflammatory response in the brain (1-3). This persists in spite of a number of studies showing that the pathological hallmarks of the prion diseases (PrPSc deposition, astrocytosis, vacuolation, and neuronal loss) are associated with the presence of activated microglia (4-7). At the heart of this discrepancy is a simple matter of what is meant by inflammation. The innate inflammatory response is the tissue's response to injury or infection, and, as so succinctly put by Metchnikoff in the late ninetenth century, "The essential and primary element in typical inflammation consists in a reaction of the phagocytes against a harmful agent" (8). Given that the microglia are the brain's resident macrophages (i.e., phagocytic cells), we believe that the presence of activated microglia in prion-affected brains represents an inflammatory response (9-11).
More Related Videos
Related Concept Videos
Encephalitis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology
Bacterial Meningitis
Alzheimer Disease ll: Pathophysiology

